Cancer research for medical purposes, namely, in the field of treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Drug development, namely, in the field of treatment of solid tumor cancers by TIL therapy; Pharmaceutical research, namely, in the field of treatment of solid tumor cancers by TIL therapy; scientific research in the nature of conducting clinical trials for others in the field of treatment of solid tumor cancers by TIL therapy; Biomedical research, namely, in the field of treatment of solid tumor cancers by TIL therapy; medical research, namely, in the field of treatment of solid tumor cancers by TIL therapy

'biomed':75 'cancer':1,15,33,48,71,86,101 'clinic':59 'conduct':58 'develop':23 'drug':22 'field':9,27,42,65,80,95 'infiltr':18 'lymphocyt':19 'medic':4,90 'name':6,24,39,77,92 'natur':56 'other':62 'pharmaceut':37 'purpos':5 'research':2,38,53,76,91 'scientif':52 'solid':13,31,46,69,84,99 'therapi':21,36,51,74,89,104 'til':20,35,50,73,88,103 'treatment':11,29,44,67,82,97 'trial':60 'tumor':14,17,32,47,70,85,100

GRIT BIOTECHNOLOGY

Owners

Goods & Services